Works matching IS 13866346 AND DT 2023 AND VI 53 AND IP 6

Results: 10
    1
    2
    3
    4
    5

    The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 511, doi. 10.1111/hepr.13886
    By:
    • Matoya, Sho;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kuroyanagi, Keita;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Miyaki, Tomokatsu;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    6

    Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 489, doi. 10.1111/hepr.13890
    By:
    • Oeda, Satoshi;
    • Seko, Yuya;
    • Hayashi, Hideki;
    • Arai, Taeang;
    • Iwaki, Michihiro;
    • Yoneda, Masato;
    • Shima, Toshihide;
    • Notsumata, Kazuo;
    • Ikegami, Tadashi;
    • Fujii, Hideki;
    • Toyoda, Hidenori;
    • Miura, Kouichi;
    • Morishita, Asahiro;
    • Kawata, Kazuhito;
    • Tomita, Kengo;
    • Kawanaka, Miwa;
    • Isoda, Hiroshi;
    • Yamaguchi, Kanji;
    • Fukushima, Hideaki;
    • Kamada, Yoshihiro
    Publication type:
    Article
    7
    8
    9
    10

    Issue Information.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 477, doi. 10.1111/hepr.13783
    Publication type:
    Article